Company registration number 04941434 (England and Wales)
ALLEGRA-LUX LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
PAGES FOR FILING WITH REGISTRAR
ALLEGRA-LUX LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 8
ALLEGRA-LUX LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
3
19,305
353,234
Investment property
4
1,850,354
1,850,354
Investments
5
170
15,170
1,869,829
2,218,758
Current assets
Debtors
6
196,330
181,183
Cash at bank and in hand
54,319
10,711
250,649
191,894
Creditors: amounts falling due within one year
7
(133,556)
(74,247)
Net current assets
117,093
117,647
Total assets less current liabilities
1,986,922
2,336,405
Creditors: amounts falling due after more than one year
8
(874,410)
(1,313,475)
Provisions for liabilities
10,694
(52,354)
Net assets
1,123,206
970,576
Capital and reserves
Called up share capital
2
2
Revaluation reserve
9
342,154
342,154
Profit and loss reserves
781,050
628,420
Total equity
1,123,206
970,576
ALLEGRA-LUX LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 DECEMBER 2024
31 December 2024
- 2 -

For the financial year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 30 September 2025 and are signed on its behalf by:
Mr D K Cresswell
Director
Company registration number 04941434 (England and Wales)
ALLEGRA-LUX LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 3 -
1
Accounting policies
Company information

Allegra-Lux Limited is a private company limited by shares incorporated in England and Wales. The registered office is Oculis House, Eddystone Road, Totton, Southampton, Hampshire, United Kingdom, SO40 3SA.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

 

When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Freehold land and buildings
Not depreciated
Fixtures and fittings
25% reducing balance
Computers
33% reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Investment property

Investment property, which is property held to earn rentals and/or for capital appreciation, is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value at the reporting end date. Changes in fair value are recognised in profit or loss.

1.5
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

ALLEGRA-LUX LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 4 -

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets. A provision is made for any impairment loss and taken to the profit and loss account.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Financial instruments

The company only enters into Basic financial instrument transactions.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

ALLEGRA-LUX LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 5 -
Current tax

The current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period.

Deferred tax

Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in the tax assessments.

 

Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

 

The company's liability for current and deferred tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.13
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
2
3
ALLEGRA-LUX LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 6 -
3
Tangible fixed assets
Freehold land and buildings
Fixtures and fittings
Computers
Total
£
£
£
£
Cost
At 1 January 2024
343,206
30,097
2,696
375,999
Additions
20,354
-
0
-
0
20,354
Disposals
(344,255)
(30,097)
(2,696)
(377,048)
At 31 December 2024
19,305
-
0
-
0
19,305
Depreciation and impairment
At 1 January 2024
-
0
21,176
1,589
22,765
Depreciation charged in the year
-
0
2,230
369
2,599
Eliminated in respect of disposals
-
0
(23,406)
(1,958)
(25,364)
At 31 December 2024
-
0
-
0
-
0
-
0
Carrying amount
At 31 December 2024
19,305
-
0
-
0
19,305
At 31 December 2023
343,206
8,921
1,107
353,234
4
Investment property
2024
£
Fair value
At 1 January 2024 and 31 December 2024
1,850,354

The fair value of the investment property has been arrived at on the basis of a valuation carried out at the year end by the company directors. The valuation was made on an open market value basis by reference to market evidence of transaction prices for similar properties and guidance of a local estate agent.

5
Fixed asset investments
2024
2023
£
£
Shares in group undertakings and participating interests
170
15,170
ALLEGRA-LUX LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
5
Fixed asset investments
(Continued)
- 7 -
Movements in fixed asset investments
Shares in associates
£
Cost or valuation
At 1 January 2024 & 31 December 2024
15,170
Carrying amount
At 31 December 2024
15,170
At 31 December 2023
15,170
Error! Does not agree to TB:
170
Difference
15,000
6
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
31,420
11,580
Other debtors
164,910
169,603
196,330
181,183
7
Creditors: amounts falling due within one year
2024
2023
£
£
Bank loans
10,000
10,000
Trade creditors
56,018
17,632
Corporation tax
31,854
97
Other taxation and social security
-
0
4,641
Other creditors
34,309
40,577
Accruals and deferred income
1,375
1,300
133,556
74,247
8
Creditors: amounts falling due after more than one year
2024
2023
£
£
Bank loans and overdrafts
5,000
15,000
Other creditors
869,410
1,298,475
874,410
1,313,475
ALLEGRA-LUX LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 8 -
9
Revaluation reserve
2024
2023
£
£
At the beginning and end of the year
342,154
342,154
10
Related party transactions

The company has taken advantage of the provision of FRS102 not to disclose transactions with other group companies.

2024-12-312024-01-01falsefalsefalse30 September 2025CCH SoftwareCCH Accounts Production 2025.100No description of principal activityMr D K CresswellMr P E ElseyMr D K Cresswell049414342024-01-012024-12-31049414342024-12-31049414342023-12-3104941434core:LandBuildingscore:OwnedOrFreeholdAssets2024-12-3104941434core:FurnitureFittings2024-12-3104941434core:ComputerEquipment2024-12-3104941434core:LandBuildingscore:OwnedOrFreeholdAssets2023-12-3104941434core:FurnitureFittings2023-12-3104941434core:ComputerEquipment2023-12-3104941434core:ShareCapital2024-12-3104941434core:ShareCapital2023-12-3104941434core:RevaluationReserve2024-12-3104941434core:RevaluationReserve2023-12-3104941434core:RetainedEarningsAccumulatedLosses2024-12-3104941434core:RetainedEarningsAccumulatedLosses2023-12-3104941434bus:CompanySecretaryDirector12024-01-012024-12-3104941434core:LandBuildingscore:OwnedOrFreeholdAssets2024-01-012024-12-3104941434core:FurnitureFittings2024-01-012024-12-3104941434core:ComputerEquipment2024-01-012024-12-31049414342023-01-012023-12-3104941434core:LandBuildingscore:OwnedOrFreeholdAssets2023-12-3104941434core:FurnitureFittings2023-12-3104941434core:ComputerEquipment2023-12-31049414342023-12-3104941434core:CurrentFinancialInstruments2024-12-3104941434core:CurrentFinancialInstruments2023-12-3104941434core:Non-currentFinancialInstruments2024-12-3104941434core:Non-currentFinancialInstruments2023-12-3104941434bus:PrivateLimitedCompanyLtd2024-01-012024-12-3104941434bus:SmallCompaniesRegimeForAccounts2024-01-012024-12-3104941434bus:FRS1022024-01-012024-12-3104941434bus:AuditExemptWithAccountantsReport2024-01-012024-12-3104941434bus:Director12024-01-012024-12-3104941434bus:Director22024-01-012024-12-3104941434bus:CompanySecretary12024-01-012024-12-3104941434bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP